Additionally, miR-221 modulates several gene targets involved in cancer-related pathways, including PTEN (P13K/AKT/mTOR), CDKN1B/p27, and CDKN1C/p57 (Fornari et al., 2008; Garofalo et al., 2009). This evidence concerns the gene CDKN1B and cancer.